NuShores Biosciences, LLC (NuShores), founded in 2014, was formed to commercialize patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock from over $9 million in grant research to date. We have recruited nationally recognized business, technology and medical experts for advisors, directors, and future senior executives. We are committed to improve the life of people with severe tissue regeneration needs and conditions. We are committed to working collaboratively with institutions of higher education, medical hospitals, and strategic partners to bring our disruptive technologies to market so as to achieve the greater good of improving lives to people in need. To positively impact our community and the world